Data / Research funding / Stellenbosch University
Stellenbosch University: 32 NIH awards ($34.2M), fiscal years 2021 to 2026
Stellenbosch University in Stellenbosch is funded under 32 NIH awards ($34.2M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- C6CHDMTANVS3UEI
Awards
32 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Stellenbosch University Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,524,563 | April 15, 2007 | November 30, 2027 | HESSELING, ANNEKE CATHARINA | reporter.nih.gov |
| Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,559,114 | June 17, 2020 | January 31, 2027 | WALZL, GERHARD | reporter.nih.gov |
| Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,440,431 | May 1, 2025 | April 30, 2028 | SEDDON, JAMES ALEXANDER | reporter.nih.gov |
| Understanding ischemia in children with tuberculous meningitis (iThemba) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,692,676 | August 1, 2022 | May 31, 2027 | SEDDON, JAMES ALEXANDER | reporter.nih.gov |
| Research for Ethical Data Science in Southern Africa (REDSSA) | NIH | National Institute of Mental Health | 2021 to 2024 | $1,570,401 | September 15, 2021 | July 31, 2026 | MOODLEY, KEYMANTHRI | reporter.nih.gov |
| Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | NIH | Fogarty International Center | 2021 to 2025 | $1,565,234 | June 19, 2017 | April 30, 2027 | YOUNG, TARYN NATALIE | reporter.nih.gov |
| CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,544,036 | August 29, 2020 | June 30, 2027 | TOMLINSON, MARK | reporter.nih.gov |
| The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk. | NIH | National Institute of Mental Health | 2023 to 2025 | $1,462,212 | March 1, 2023 | December 31, 2027 | TANSER, FRANK COURTENEY | reporter.nih.gov |
| Harnessing male peer networks to enhance engagement with HIV prevention: A largescale cluster randomized trial to increase HIV self-testing and PrEP uptake | NIH | National Institute of Mental Health | 2023 to 2025 | $1,452,713 | August 3, 2023 | May 31, 2028 | TANSER, FRANK COURTENEY | reporter.nih.gov |
| Urine tenofovir point-of-care test to identify patients in need of ART adherence support | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,340,853 | July 7, 2020 | June 30, 2026 | VAN ZYL, GERT UVES | reporter.nih.gov |
| MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,316,463 | April 3, 2020 | March 31, 2026 | GRAY, CLIVE MAURICE | reporter.nih.gov |
| Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,286,699 | April 6, 2020 | March 31, 2026 | SAMPSON, SAMANTHA LEIGH | reporter.nih.gov |
| Next Generation Training in HIV Research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | NIH | Fogarty International Center | 2024 to 2025 | $606,800 | April 1, 2024 | December 31, 2028 | GRAY, CLIVE MAURICE | reporter.nih.gov |
| The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | NIH | Fogarty International Center | 2021 to 2024 | $533,615 | August 1, 2020 | July 31, 2025 | VAN DER ZALM, MARIEKE MARGREET | reporter.nih.gov |
| Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | NIH | Fogarty International Center | 2021 to 2024 | $521,382 | February 5, 2020 | January 31, 2026 | DU PREEZ, KAREN | reporter.nih.gov |
| African Tuberculosis Bioinformatics Training Program | NIH | Fogarty International Center | 2024 to 2025 | $495,503 | May 1, 2024 | April 30, 2029 | SAMPSON, SAMANTHA LEIGH | reporter.nih.gov |
| Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $408,266 | June 20, 2019 | May 31, 2025 | STREICHER, ELIZABETH MARIA | reporter.nih.gov |
| Pre- and post-treatment lung microbiota, metabolome and immune signatures at the site of disease in patients with active pulmonary tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $392,424 | June 11, 2019 | May 31, 2025 | THERON, GRANT DE VOS | reporter.nih.gov |
| Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients | NIH | Fogarty International Center | 2022 to 2025 | $357,782 | July 27, 2022 | June 30, 2027 | NAIDOO, CHARISSA CAMILLE | reporter.nih.gov |
| CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $334,696 | August 29, 2020 | June 30, 2023 | SLOGROVE, AMY LOUISE | reporter.nih.gov |
| Development of a Next-generation Rapid Phenotypic Assay for Drug-Resistant M. tuberculosis | NIH | Fogarty International Center | 2023 to 2025 | $318,264 | July 15, 2023 | April 30, 2028 | KLOPPER, MARISA | reporter.nih.gov |
| Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | NIH | Fogarty International Center | 2023 to 2024 | $304,406 | August 7, 2023 | June 30, 2025 | DECLOEDT, ERIC HERMANN | reporter.nih.gov |
| Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | NIH | Fogarty International Center | 2021 to 2022 | $302,336 | August 11, 2021 | May 31, 2025 | DECLOEDT, ERIC HERMANN | reporter.nih.gov |
| A comprehensive whole genome sequence scan for positive selection in southern Africa | NIH | Fogarty International Center | 2023 to 2025 | $300,491 | July 21, 2023 | April 30, 2027 | UREN, CAITLIN | reporter.nih.gov |
| Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen) | NIH | Fogarty International Center | 2022 to 2023 | $298,750 | September 12, 2022 | June 30, 2025 | STRIJDOM, HANS | reporter.nih.gov |
| Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $258,202 | March 5, 2018 | February 28, 2025 | STRAUSS, ERICK | reporter.nih.gov |
| Advancing Research Ethics Training in Southern Africa (ARESA): Leadership Program | NIH | Fogarty International Center | 2021 | $248,400 | June 1, 2017 | May 31, 2025 | MOODLEY, KEYMANTHRI | reporter.nih.gov |
| African Tuberculosis Bioinformatics Training Program | NIH | Fogarty International Center | 2021 to 2022 | $216,000 | August 1, 2021 | March 31, 2024 | SAMPSON, SAMANTHA LEIGH | reporter.nih.gov |
| Mycobacterial Epigenetics: Investigating the impact of DNA methylation on antibiotic tolerance and persistence | NIH | Fogarty International Center | 2024 to 2025 | $213,174 | September 1, 2024 | August 31, 2029 | KRIEL, NASTASSJA LISE | reporter.nih.gov |
| The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | NIH | Fogarty International Center | 2021 | $194,397 | August 22, 2017 | August 31, 2023 | SLOGROVE, AMY LOUISE | reporter.nih.gov |
| Cardiovascular magnetic resonance assessment of subclinicalcardiovascular abnormalities before and after the initiation of antiretroviral therapy in HIV-infected South Africans | NIH | Fogarty International Center | 2024 | $100,559 | September 11, 2024 | August 31, 2029 | ROBBERTSE, PIETER-PAUL STRAUSS | reporter.nih.gov |
| Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | NIH | Fogarty International Center | 2022 to 2023 | $60,480 | April 1, 2022 | February 28, 2025 | GRAY, CLIVE MAURICE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 14 | $6,384,514 | 0 | $0 |
| 2024 | 23 | $8,720,105 | 0 | $0 |
| 2023 | 22 | $8,338,509 | 0 | $0 |
| 2022 | 16 | $4,552,337 | 0 | $0 |
| 2021 | 17 | $6,225,857 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants | PAR-26-144 | NIH | 93.989 | November 15, 2026 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.989 | November 16, 2026 | $50,000 | Same assistance listing 93.989 as 17 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.989 | November 18, 2026 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 17 awards here |
| International Research Scientist Development Award (IRSDA) | PAR-28-040 | NIH | 93.989 | February 9, 2027 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes | PAR-28-039 | NIH | 93.989 | February 11, 2027 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Implementation and Evaluation of Databases to Examine AIDS | RFA-AI-28-025 | NIH | 93.989 | May 27, 2027 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) | RFA-TW-28-001 | NIH | 93.989 | September 22, 2027 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Emerging Global Leader Award (K43) | PAR-28-070 | NIH | 93.989 | October 12, 2027 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-25-143 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-25-233 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | PA-26-001 | NIH | 93.989 | November 30, 2028 | Not listed | Same assistance listing 93.989 as 17 awards here |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) | PA-26-002 | NIH | 93.989 | May 7, 2029 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) | PAR-28-090 | NIH | 93.989 | May 25, 2029 | Not listed | Same assistance listing 93.989 as 17 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
Topics of its NIH awards
- Infectious Diseases
- Clinical Research
- HIV/AIDS
- Emerging Infectious Diseases
- Rare Diseases
- Tuberculosis
- Biodefense and Related Countermeasures
- Prevention
- Pediatric
- Lung
- Orphan Drug
- Antimicrobial Resistance
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.